Oncology & Cancer

One in 10 US women miss cervical cancer screenings

Eight million US women have not been screened in the last five years for cervical cancer, even though regular checkups can help prevent the fatal disease, US health authorities said Wednesday.

Oncology & Cancer

US OKs first-ever DNA alternative to Pap smear (Update 2)

U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap smear, the decades-old mainstay of women's health.

Oncology & Cancer

DNA alternative to Pap smear sparks medical debate (Update)

A high-tech screening tool for cervical cancer is facing pushback from more than a dozen American patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: ...

Oncology & Cancer

HPV home tests could identify cancer risk

HPV self-testing is as effective as tests done by doctors, according to a Lund University study. Simple HPV home tests could therefore complement existing screening programmes, and identify more women at risk for cervical ...

Oncology & Cancer

How a routine pap smear ends up costing $1,000

(HealthDay)—When doctors think about tests that might cause sticker shock for their patients, they wouldn't normally consider a simple Pap smear.

Oncology & Cancer

Too many Pap tests

Most Australian women are currently having more Pap smears than their health requires, according to new research led by a University of New South Wales academic.

Oncology & Cancer

Transforming cervical screening

(Medical Xpress)—There is nothing like a big celebrity name to create global attention to a big health concern. As a result we now have the 'Jolie effect' to describe the influence actress Angelina Jolie has had on people ...

page 3 from 5